These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 26244757)

  • 21. In vivo fluorescence detection of ovarian cancer in the NuTu-19 epithelial ovarian cancer animal model using 5-aminolevulinic acid (ALA).
    Major AL; Rose GS; Chapman CF; Hiserodt JC; Tromberg BJ; Krasieva TB; Tadir Y; Haller U; DiSaia PJ; Berns MW
    Gynecol Oncol; 1997 Jul; 66(1):122-32. PubMed ID: 9234932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Folate Receptor Targeted Photodynamic Therapy: A Novel Way to Stimulate Anti-Tumor Immune Response in Intraperitoneal Ovarian Cancer.
    Baydoun M; Boidin L; Leroux B; Vignion-Dewalle AS; Quilbe A; Grolez GP; Azaïs H; Frochot C; Moralès O; Delhem N
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in the mitochondrial responses to PENAO as a mechanism of resistance in ovarian cancer cells.
    Decollogne S; Joshi S; Chung SA; Luk PP; Yeo RX; Nixdorf S; Fedier A; Heinzelmann-Schwarz V; Hogg PJ; Dilda PJ
    Gynecol Oncol; 2015 Aug; 138(2):363-71. PubMed ID: 26080289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Near-infrared fluorescent imaging of metastatic ovarian cancer using folate receptor-targeted high-density lipoprotein nanocarriers.
    Corbin IR; Ng KK; Ding L; Jurisicova A; Zheng G
    Nanomedicine (Lond); 2013 Jun; 8(6):875-90. PubMed ID: 23067398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IMGN853, a Folate Receptor-α (FRα)-Targeting Antibody-Drug Conjugate, Exhibits Potent Targeted Antitumor Activity against FRα-Expressing Tumors.
    Ab O; Whiteman KR; Bartle LM; Sun X; Singh R; Tavares D; LaBelle A; Payne G; Lutz RJ; Pinkas J; Goldmacher VS; Chittenden T; Lambert JM
    Mol Cancer Ther; 2015 Jul; 14(7):1605-13. PubMed ID: 25904506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissemination of intraperitoneal ovarian cancer: Discussion of mechanisms and demonstration of lymphatic spreading in ovarian cancer model.
    Feki A; Berardi P; Bellingan G; Major A; Krause KH; Petignat P; Zehra R; Pervaiz S; Irminger-Finger I
    Crit Rev Oncol Hematol; 2009 Oct; 72(1):1-9. PubMed ID: 19179094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 rat.
    Rose GS; Tocco LM; Granger GA; DiSaia PJ; Hamilton TC; Santin AD; Hiserodt JC
    Am J Obstet Gynecol; 1996 Sep; 175(3 Pt 1):593-9. PubMed ID: 8828419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary folate and related micronutrients, folate-metabolising genes, and ovarian cancer survival.
    Dixon SC; Ibiebele TI; Protani MM; Beesley J; deFazio A; Crandon AJ; Gard GB; Rome RM; Webb PM; Nagle CM;
    Gynecol Oncol; 2014 Mar; 132(3):566-72. PubMed ID: 24368279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel expression of CD11b in epithelial ovarian cancer: Potential therapeutic target.
    Saed GM; Fletcher NM; Diamond MP; Morris RT; Gomez-Lopez N; Memaj I
    Gynecol Oncol; 2018 Mar; 148(3):567-575. PubMed ID: 29329880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploiting the folate receptor α in oncology.
    Scaranti M; Cojocaru E; Banerjee S; Banerji U
    Nat Rev Clin Oncol; 2020 Jun; 17(6):349-359. PubMed ID: 32152484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The feasibility of folate receptor alpha- and HER2-targeted intraoperative fluorescence-guided cytoreductive surgery in women with epithelial ovarian cancer: A systematic review.
    de Jong JM; Hoogendam JP; Braat AJAT; Zweemer RP; Gerestein CG
    Gynecol Oncol; 2021 Aug; 162(2):517-525. PubMed ID: 34053747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-Folate Receptor Alpha-Directed Antibody Therapies Restrict the Growth of Triple-negative Breast Cancer.
    Cheung A; Opzoomer J; Ilieva KM; Gazinska P; Hoffmann RM; Mirza H; Marlow R; Francesch-Domenech E; Fittall M; Dominguez Rodriguez D; Clifford A; Badder L; Patel N; Mele S; Pellizzari G; Bax HJ; Crescioli S; Petranyi G; Larcombe-Young D; Josephs DH; Canevari S; Figini M; Pinder S; Nestle FO; Gillett C; Spicer JF; Grigoriadis A; Tutt ANJ; Karagiannis SN
    Clin Cancer Res; 2018 Oct; 24(20):5098-5111. PubMed ID: 30068707
    [No Abstract]   [Full Text] [Related]  

  • 33. Eradication of growth of HER2-positive ovarian cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate in mouse xenograft model.
    Yu L; Wang Y; Yao Y; Li W; Lai Q; Li J; Zhou Y; Kang T; Xie Y; Wu Y; Chen X; Yi C; Gou L; Yang J
    Int J Gynecol Cancer; 2014 Sep; 24(7):1158-64. PubMed ID: 24987913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer.
    Tjhay F; Motohara T; Tayama S; Narantuya D; Fujimoto K; Guo J; Sakaguchi I; Honda R; Tashiro H; Katabuchi H
    Cancer Sci; 2015 Oct; 106(10):1421-8. PubMed ID: 26250934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake.
    Hiramatsu K; Serada S; Enomoto T; Takahashi Y; Nakagawa S; Nojima S; Morimoto A; Matsuzaki S; Yokoyama T; Takahashi T; Fujimoto M; Takemori H; Ueda Y; Yoshino K; Morii E; Kimura T; Naka T
    Cancer Res; 2018 Jan; 78(2):516-527. PubMed ID: 29187404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modification of cytokine-induced killer cells with folate receptor alpha (FRα)-specific chimeric antigen receptors enhances their antitumor immunity toward FRα-positive ovarian cancers.
    Zuo S; Wen Y; Panha H; Dai G; Wang L; Ren X; Fu K
    Mol Immunol; 2017 May; 85():293-304. PubMed ID: 28360017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human embryonic stem cells--a potential vaccine for ovarian cancer.
    Zhang ZJ; Chen XH; Chang XH; Ye X; Li Y; Cui H
    Asian Pac J Cancer Prev; 2012; 13(9):4295-300. PubMed ID: 23167331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis.
    Klymenko Y; Kim O; Loughran E; Yang J; Lombard R; Alber M; Stack MS
    Oncogene; 2017 Oct; 36(42):5840-5851. PubMed ID: 28628116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased expression of heat shock protein 27 correlates with peritoneal metastasis in epithelial ovarian cancer.
    Zhao M; Shen F; Yin YX; Yang YY; Xiang DJ; Chen Q
    Reprod Sci; 2012 Jul; 19(7):748-53. PubMed ID: 22534325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis.
    Werner ME; Karve S; Sukumar R; Cummings ND; Copp JA; Chen RC; Zhang T; Wang AZ
    Biomaterials; 2011 Nov; 32(33):8548-54. PubMed ID: 21843904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.